Balance Awareness Week

Welcome to the ICU podcast, where we illuminate invisible chronic illnesses and the people who live with them. In this episode, we’re spotlighting Balance Awareness Week, an annual event hosted by the Vestibular Disorders Association each September. This global campaign raises awareness about the impact of vestibular disorders—conditions that affect balance, dizziness, and spatial orientation—and connects patients, caregivers, and healthcare professionals through education and advocacy. In this episode, we talk with Paul Morris, VeDA’s Development Director, about how people can get involved in Balance Awareness Week, as well as Christian Chabbert, a French neurophysiologist who engages healthcare professionals across Europe in this event, and is spearheading a global walk for balance.Speaker BiosPaul Morris has over 30 years of experience in nonprofit fundraising, helping a wide spectrum of organizations raise millions of dollars to support their missions. He has led successful development efforts in direct health services at the state and national levels. He’s also helped raise funds for organizations that work in regional theater, architectural preservation, offering chess to low-income students, and more. For Paul, fund development isn’t just about raising money, but building relationships with people in your community so that they feel heard, valued, and are excited about supporting their shared mission. Christian Chabbert is a French neurophysiologist and Research Director at the French National Centre for Scientific Research. He is developing research on balance disorders at the Research Center in Psychology and Neurosciences at Aix-Marseille University. Since 2015, Dr. Chabbert has directed GDR Vertige, a national research consortium uniting clinicians, scientists, and industry partners to advance the understanding and treatment of vestibular disorders. His expertise in sensory neuroscience and molecular electrophysiology has contributed to over 90 scientific publications and the founding of two biotech companies—Sensorion Pharmaceuticals and Vertidiag—focused on developing therapies for balance-related conditions. Dr. Chabbert also plays a key role in the European PROVIDE network, promoting translational research and innovation in neuro-otology across Europe.